Global Neurology Academy

The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.

For more information about GNA, visit www.globalneurologyacademy.org.

403

LikeLikedUnlike

1-15 of 232

The Critical Next Steps After Subarachnoid Hemorrhage Diagnosis
NeuroFrontiers
The Critical Next Steps After Subarachnoid Hemorrhage Diagnosis
- Jay Max Findlay
Evaluating Delayed Presentations of Subarachnoid Hemorrhage
NeuroFrontiers
Evaluating Delayed Presentations of Subarachnoid Hemorrhage
- Jay Max Findlay
Spotting the Warning Signs of Subarachnoid Hemorrhage
NeuroFrontiers
Spotting the Warning Signs of Subarachnoid Hemorrhage
- Jay Max Findlay
The Recovery Trajectory of Subarachnoid Hemorrhage
NeuroFrontiers
The Recovery Trajectory of Subarachnoid Hemorrhage
- Jay Max Findlay
Mobilization Outcomes After Aneurysmal Subarachnoid Hemorrhage
NeuroFrontiers
Mobilization Outcomes After Aneurysmal Subarachnoid Hemorrhage
Consensus-Driven Outcomes for Aneurysmal Subarachnoid Hemorrhage Research
NeuroFrontiers
Consensus-Driven Outcomes for Aneurysmal Subarachnoid Hemorrhage Research
advertisement
How Real-World Adherence Is Shaping Preventive Migraine Treatment
NeuroFrontiers
How Real-World Adherence Is Shaping Preventive Migraine Treatment
- Alexandria May, PharmD, BCPS
- Jessica Ailani, MD, FAHS, FAAN, FANA
CME/CE Virtual Event
When “Mild” Matters Most: Closing Clinical Gaps in Early Symptomatic Alzheimer’s Disease
Multiple dates available
1.00 credits
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
NeuroFrontiers
Vagus Nerve Stimulation Shows Short-Term Benefit in Chronic Migraine Trial
Rethinking Vestibular Migraine in Clinical Practice
NeuroFrontiers
Rethinking Vestibular Migraine in Clinical Practice
Insights on Migraine Care Disparities from OVERCOME
AudioAbstracts
Insights on Migraine Care Disparities from OVERCOME
- Ryan Quigley
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
NeuroFrontiers
Identifying the Respiratory Manifestations of TK2d: The Pulmonologist’s Role
- Charles Turck, PharmD, BCPS, BCCCP
- Bethany Lussier, MD
advertisement
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
NeuroFrontiers
Recognizing TK2d: Key Clinical Signs and Diagnostic Protocols
- Alexandria May, PharmD, BCPS
- Kaitlin Batley, MD
FXIa Remix! Keeping the Flow Without Missing a Beat
CME/CE
FXIa Remix! Keeping the Flow Without Missing a Beat
- Mike Sharma, MD, MSc, FRCPC
- Ashkan Shoamanesh, MD
- Brian Mac Grory, MB, BCh BAO, MRCP, FAHA, FANA
0.50 credits
Understanding Variability in Myasthenia Gravis
NeuroFrontiers
Understanding Variability in Myasthenia Gravis
- Henry Kaminski, MD